Physician
Hematology
Dr. Khaldoun Almhanna, MD
|
|
Give Review
Doctor Khaldoun Almhanna, MD is an expert in the field of Hematology. He received awards:"Whos Who in Medicine and Healthcare". Dr. Khaldoun Almhanna is a published MD as well. He has 46 publications published. The latest was: The prognostic value of residual nodal disease following neoadjuvant chemoradiation for esophageal cancer in patients with complete primary tumor response. Khaldoun Almhanna is registered with Medicare and accepts Medicare payments.
Publications
- The prognostic value of residual nodal disease following neoadjuvant chemoradiation for esophageal Cancer in patients with complete primary tumor response.
- Esophageal Cancer 2015, more questions than answers.
- Robotic assisted Ivor Lewis esophagectomy in the elderly patient.
- Concurrent chemoradiotherapy with protracted infusion of 5-fluorouracil (5-FU) and cisplatin for locally advanced resectable esophageal Cancer.
- Current status of novel agents in advanced gastroesophageal adenoCarcinoma.
- A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the ...
- Carboplatin and paclitaxel as first-line treatment of unresectable or metastatic esophageal or gastric Cancer.
- Single-Institution Retrospective Comparison of Preoperative Versus Definitive Chemoradiotherapy for AdenoCarcinoma of the Esophagus.
- Comparative outcomes for three-dimensional conformal versus intensity-modulated radiation therapy for esophageal Cancer.
- Effect of Body Mass Index in Patients Undergoing Resection for Gastric Cancer: A Single Center US Experience.
- Prognostic impact of lymph node retrieval and ratio in gastric Cancer: a u.s. Single center experience.
- Adjuvant Radiation Therapy and Lymphadenectomy in Esophageal Cancer: A SEER Database Analysis.
- MK-2206, an Akt inhibitor, enhances carboplatinum/paclitaxel efficacy in gastric cancer Cell lines.
- Extent of Lymphadenectomy Does Not Predict Survival in Patients Treated with Primary Esophagectomy.
- Defining the Learning Curve for Robotic-assisted Esophagogastrectomy.
- Lymph Node Harvest in Esophageal Cancer After Neoadjuvant Chemoradiotherapy.
- The impact of body mass index on esophageal Cancer.
- Endoscopic Therapy of Neoplasia Related to Barrett's Esophagus and Endoscopic Palliation of Esophageal Cancer.
- Targeting the human epidermal growth factor receptor 2 in esophageal Cancer.
- Radiation therapy and esophageal Cancer.
- Neoadjuvant or adjuvant therapy for resectable esophageal Cancer: is there a standard of care?
- Outcomes Associated with Surgery for T4 Esophageal Cancer.
- Increased survival associated with surgery and radiation therapy in metastatic gastric Cancer: A Surveillance, Epidemiology, and End Results database analysis.
- Body mass index and perioperative complications after oesophagectomy for adenoCarcinoma: a systematic database review.
- Reactivation of p53 by novel MDM2 inhibitors: implications for pancreatic Cancer therapy.
- A phase II study of bevacizumab, oxaliplatin, and docetaxel in locally advanced and metastatic gastric and gastroesophageal junction Cancers.
- Predictors of clinical outcomes of resected ampullary adenoCarcinoma: a single-institution experience.
- Proliferative and morphological effects of endothelins in Schwann Cells: roles of p38 mitogen-activated protein kinase and Ca(2+)-independent phospholipase A2.
- Endothelins regulate arachidonic acid release and mitogen-activated protein kinase activity in Schwann Cells.
- Targeting AKT protein kinase in gastric Cancer.
- Defining new paradigms for the treatment of pancreatic Cancer.
- Differentially expressed miRNAs in the plasma may provide a molecular signature for aggressive pancreatic Cancer.
- Safety and efficacy of sorafenib in the treatment of hepatoCellular carcinoma.
- Impact of race, age, and socioeconomic status on participation in pancreatic Cancer clinical trials.
- A single institution review of adjuvant therapy outcomes for resectable pancreatic adenoCarcinoma: outcome and prognostic indicators.
- MDM2 inhibitors for pancreatic Cancer therapy.
- Intracerebral Hodgkin's Lymphoma in a patient with chronic lymphocytic leukemia/small lymphocytic Lymphoma: a case report and literature review.
- Second-line therapy for gemcitabine-refractory pancreatic Cancer: is there a standard?
- Subcutaneous implantable venous access device erosion through the Skin in patients treated with anti-vascular endothelial growth factor therapy: a case series.
- Neoadjuvant therapy for hepatoCellular carcinoma: is there an optimal approach?
- Capecitabine vs continuous infusion 5-FU in neoadjuvant treatment of rectal Cancer. A retrospective review.
- Sideroblastic anemia after bariatric surgery.
- Transient expression of hypoxia-inducible factor-1 alpha and target genes in peripheral nerves from diabetic rats.
- Unilateral brachial plexopathy associated with West Nile virus meningoencephalitis.
- Hyperglycemia triggers abnormal signaling and proliferative responses in Schwann Cells.
Conditions Treated
- Basal Cell Carcinoma
- Bile Duct Cancer
- Cancer
- Central Nervous System Lymphoma
- View All
Doctors Specialties
- Oncology
- Hematology
Accepted Insurances
Awards
- Whos Who in Medicine and Healthcare
Education
-
Cleveland Clinic Foundation -
Damascus University Faculty of Medicine
Hospital
-
Tampa General Hospital -
H. Lee Moffitt Cancer Center and Research Institute
Drug Facts
| NPI NUMBER | 1790977650 | |
| NPPES Provider LastName | ALMHANNA | |
| NPPES Provider FirstName | KHALDOUN | |
| NPPES Provider ZIPCode | 336129416 | |
| NPPES Provider State | FL | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 738.0 | |
| Distinct Opioid Count | 5.0 | |
| Opioid Claim Count | 134.0 | |
| Percent Opioid Claims | 18.16 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1790977650 |
| Last Name Of The Provider | ALMHANNA |
| First Name Of The Provider | KHALDOUN |
| View All |
Similar Doctors
|
Dr. Jason B. Brayer, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Lubomir Sokol, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph G. Sinkovics, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Marcie R. Tomblyn, MD |
|
Dr. Egberto J. Zayas, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Eric Padron, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John D. Accomando, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Omayra Reyes Santiago, MD |
|
|
Dr. Melanie A. Sheen, MD |